R Squared’s GoodRx Holdings GDRX Stock Holding History

R Squared’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-850	Closed	-$3.95K	–	751
2024 Q4	$3.95K	Buy	+850	New	+$4.67K	﹤0.01%	1362

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

8KM

8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

R Squared's GDRX Position: Q1 2025 in Review

R Squared sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 850 shares — an estimated $3.95K sold.

R Squared first reported a position in GDRX in Q4 2024 and held it in 1 quarter. The position peaked at $3.95K in Q4 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

R Squared reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
R Squared sold 850 GoodRx Holdings shares in Q1 2025, an estimated $3.95K.
R Squared first reported a position in GoodRx Holdings in Q4 2024 and held it in 1 quarter.
R Squared's GoodRx Holdings position peaked at $3.95K in Q4 2024.
170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.